This product's status changed to Approval withdrawn on 2023.03.06. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Summary
- Main use
- Improvement of nutritional status (hypoproteinemia, malnutrition, before and after surgery, etc.)
- Who uses it
- Adults · Children
- Adult dosage
- ○Adults: Infuse intravenously a maximum dose of 1~1.5 g of total amino acids per kg of body weight per day. ○Infusion rate: A concentration of approximately 10 g of total amino acids over 60 minutes is preferred; in principle, infuse at a maximum rate of 25 drops per minute.
- Children's dosage
- In children, older adults, and burn patients with high protein requirements, adjust the dose and infusion rate appropriately.
Ingredients
- L-Isoleucine
- L-Leucine
- L-Methionine
- L-Threonine
- L-Lysine Acetate
- L-Phenylalanine
- Acetylcysteine
- L-Tryptophan
- L-Valine
- L-Arginine
- L-Histidine
- Glycine
- L-Alanine
- L-Aspartic Acid
- L-
- Manufacturer
- Daehan Pharmaceutical Co., Ltd.
Efficacy & effects
Improvement of nutritional status (hypoproteinemia, malnutrition, before and after surgery, etc.)
- Hypoalbuminemia
- malnutrition
View approved original textHide original text
This medicine is used to maintain and restore protein balance in the body by supplying amino acids in cases of hypoalbuminemia, malnutrition, and pre- and post-operative states.
Dosage and Administration
Adult dosage
○Adults: Infuse intravenously a maximum dose of 1~1.5 g of total amino acids per kg of body weight per day. ○Infusion rate: A concentration of approximately 10 g of total amino acids over 60 minutes is preferred; in principle, infuse at a maximum rate of 25 drops per minute.
Children's dosage
In children, older adults, and burn patients with high protein requirements, adjust the dose and infusion rate appropriately.
Precautions
This medication must be used according to the physician's instructions, and it should not be taken or stopped arbitrarily. It should not be administered to patients with hepatic coma or those at risk of hepatic coma, severe kidney disorders, or nitrogen metabolism disorders. Use should also be avoided in patients with severe heart failure, pulmonary edema, extremely low or no urine output, and specific electrolyte abnormalities. Additionally, it should not be given to patients with heart conduction disorders, myasthenia gravis, patients receiving excessive fluid supply, patients with acidosis, patients with hyperkalemia, neonates, children under 2 years old, and patients who have had a myocardial infarction. Caution is needed for patients with congestive heart failure or edema due to sodium retention, as well as those with liver or kidney disorders, as adverse reactions may include skin rashes, nausea, vomiting, palpitations, and blood pressure elevation. Rapid or large volume administration may result in acidosis, and symptoms such as fever, chills, headache, and shortness of breath may rarely occur, which requires caution. During the use of this medication, it is crucial to maintain a good electrolyte balance, and patients with diabetes should frequently check their blood sugar levels. There may be drug interactions with other medications; thus, caution is required if used with tetracycline antibiotics or calcium salts. Safety during pregnancy has not been established, so it should only be administered under the physician's judgment when necessary. This medication should not be given to infants under 2 years of age, and when used in children, blood ammonia levels should be frequently monitored. Elderly patients may have diminished bodily functions, so the administration rate should be slow and the dosage should be adjusted. During administration, the infusion should be given slowly IV, the temperature of the solution should be maintained at body temperature, and it is essential to prepare and manage the solution in a sterile condition. The solution should not be used if it appears discolored or cloudy prior to administration, and it should be stored in unopened packaging and used as soon as possible after opening.
Side effects
- Rash
- nausea
- vomiting
- chest discomfort
- palpitations
- tachycardia
- increased blood pressure
- acidosis
- feeling of heat
- vascular pain
Show 29 moreCollapse
- chills
- fever
- headache
- shortness of breath
- respiratory arrest
- shock
- bronchospasm
- ureteral spasm
- peripheral vascular dilation
- metabolic acidosis
- hypophosphatemia
- alkalosis
- hyperglycemia
- diabetes
- osmotic diuresis
- dehydration
- rebound hypoglycemia
- elevated liver enzymes
- vitamin deficiency
- vitamin excess
- electrolyte imbalance
- pediatric hyperammonemia
- elevated BUN
- serum amino acid imbalance
- metabolic alkalosis
- systemic nitrogenemia
- hyperammonemia
- sensory loss
- coma
Not everyone experiences these, and they can vary from person to person.
Storage
This medication should be stored in a sealed container to prevent exposure to air and moisture, preferably at room temperature between 1 and 30 degrees Celsius. Storing it this way helps to maintain the effectiveness of the medication.
Appearance and packaging
Appearance
A colorless to pale yellow transparent solution filled in a colorless transparent glass container or polypropylene container as an injectable solution.
Package unit
250mL/bottle
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.